In Silica Veritas: A Computer-Modeling Blitz Helps Speed Hands-On Discovery Of A Cancer-Fighting Compound

News — By on April 22, 2009 at 2:00 am

William Cance, MD, Chair of Surgical Oncology, Roswell Park Cancer Institute (RPCI) will present “A Small-Molecule Inhibitor, Targeting FAK and Mdm-2 Interaction, Blocks Breast and Colon Tumorigenesis in vivo” at the American Association Cancer Research (AACR) 100th Annual Meeting, 2009, April 18 -22 in Denver CO. When protein meets protein at the boundary of a cell, life-and-death messages are transmitted.

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback